Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
Vanda Pharmaceuticals (NASDAQ: VNDA) will participate in the H.C. Wainwright Global Investment Conference in New York City on September 14, 2022, at 8:30 a.m. Eastern Time. Investors can access the live corporate presentation on Vanda's official website. The company is focused on developing innovative therapies for high unmet medical needs. An archived version of the presentation will be available for approximately 30 days after the conference.
- Participation in a significant investment conference may enhance investor visibility.
- Opportunity to present innovative therapies to a broader audience, potentially attracting investment.
- None.
WASHINGTON, Sept. 8, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the company will participate in the H.C. Wainwright Global Investment Conference in New York City on Wednesday, September 14, 2022. A corporate presentation is scheduled for 8:30 a.m. Eastern Time.
The corporate presentation given at the H.C. Wainwright Global Investment Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-hc-wainwright-global-investment-conference-301620904.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
What is Vanda Pharmaceuticals announcing on September 14, 2022?
Where can I watch the Vanda Pharmaceuticals presentation?
What is the focus of Vanda Pharmaceuticals?
